Sylvant Prices, Coupons, Copay Cards & Patient Assistance
Sylvant (siltuximab) is a member of the interleukin inhibitors drug class and is commonly used for Multicentric Castleman’s Disease.
Sylvant prices
Intravenous Powder For Injection
100 mg Sylvant intravenous powder for injection from $1,708.74 for 1 powder for injection
Quantity | Per unit | Price |
---|---|---|
1 | $1,708.74 | $1,708.74 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
400 mg Sylvant intravenous powder for injection from $6,804.99 for 1 powder for injection
Quantity | Per unit | Price |
---|---|---|
1 | $6,804.99 | $6,804.99 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Sylvant Coupons, Copay Cards and Rebates
Sylvant offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Sylvant Eusa Patient Connect Co-Pay Program
Eligible commercially insured patients may pay $5 per infusion with savings of up to $26,000 per calendar year.
- Applies to:
- Sylvant
- Number of uses:
- per prescription per calendar year
Form more information phone: 855-299-8844 or Visit website
Patient Assistance & Copay Programs for Sylvant
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: R.A.R.E. Patient Support Program: Sylvant
Eligibility requirements:- Determined case by case
- Varies
- FDA-approved diagnosis
- Must be treated by US licensed healthcare provider
- Recordati Access, Resources, and Engagement (R.A.R.E.) Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please visit www.recordatirarediseases.com or call 888-855-RARE for more information
- Sylvant (siltuximab) Injection; IV
More information please phone: 855-299-8844 or 908-236-0888 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Arcalyst
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of ...
Bimzelx
Bimzelx (bimekizumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ...
Cinqair
Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Ebglyss
Ebglyss (lebrikizumab) is a treatment for moderate-to-severe atopic dermatitis given as a monthly ...
Enspryng
Enspryng is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...
More about Sylvant (siltuximab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español